Sema4 Receives Nasdaq Noncompliance Warning, Will Return $42M Under Payor Lawsuit Settlement
The company's stock price had been below $1 per share for 30 trading days prior to the notice, which Sema4 received Dec. 28.
Ambry Genetics Settles Class Action Lawsuit Over 2020 Data Breach for $12.3M
The settlement agreement, filed Sept. 9 with the US District Court for the Central District of California, does not include an admission of liability or wrongdoing by Ambry.
Inform Diagnostics to Pay $16M to Settle False Claims Allegations
Company officials performed additional tests on biopsy specimens without orders from physicians or pathologists, according to the US Department of Justice
UCSD Settles with US DOJ for $2.98M Over Allegations of False Billing for Genetic Tests
The academic health system was accused of ordering and submitting referrals for medically unnecessary genetic testing.
Qiagen Settles Becton Dickinson Patent Infringement Lawsuit for $53M
BD filed the suit against NeuMoDx, now part of Qiagen, in 2019 for infringing patents related to the use of microfluidic cartridges for molecular diagnostics.